Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and certain children. As with other drugs, Harvoni can cause side ...

Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and some children. Harvoni comes as oral tablets and pellets that ...

While still being on the receiving end for the high cost of sofosbuvir, Gilead's combination pill for Hepatitis C (sofosbuvir + ledipasvir) was today approved by the FDA. The FDA today approved ...

Kidney transplant recipients with hepatitis C virus genotype 1 or 4 were safely and effectively treated with Harvoni for up to 24 weeks, according to research published in Annals of Internal Medicine.

A $100 million ad blitz has whipped up patient demand for Harvoni, the $1,100-a-pill hepatitis C treatment, even as the drug’s price has drawn a barrage of lawsuits, state investigations, and sharp ...

Gilead is adjusting its message in new advertising for hepatitis C drug Harvoni, replacing its two-year-old introductory ad with a spot highlighting patients' relief after treatment. Three key words: ...

Gilead’s new all-in-one hepatitis C treatment Harvoni may have set the rules for drug pricing. The Wall Street Journal reports that the one-pill sofosbuvir-ledipasvir combination is probably putting ...

The US Food and Drug Administration (FDA) has okayed expanded use of the combination antiviral drug ledipasvir/sofosbuvir (Harvoni, Gilead Sciences) in patients with genotype 4, 5, and 6 chronic ...

Please provide your email address to receive an email when new articles are posted on . BARCELONA — Harvoni treatment led to sustained virologic response without significant side effects in ...

Gilead Sciences Inc.GILD announced a label expansion for its blockbuster hepatitis C virus (HCV) drug, Harvoni, for the treatment of chronic hepatitis C patients with advanced liver disease in the U.S ...

Last September, Gilead made the unexpected move of launching authorized generics to its blockbuster hepatitis C drugs Epclusa and Harvoni, well before their patients expire. Now the copycats have ...

Sometimes Jane Blumenfeld feels that if she were in prison, she would have a better chance at getting lifesaving drugs to treat her liver disease. Blumenfeld is one of 33,160 people in California who ...